I am a scientist who has transitioned into entrepreneurship, driven by a strong desire to make a positive impact. My primary focus is applying my expertise in protein engineering to discover and craft biologic anti-cancer drugs that prioritize patient well-being by ensuring their safety.I co-founded Enzyme by Design, a startup that has successfully secured $3.5 million in non-dilutive grants from the National Cancer Institute, and I currently serve as the Principal Investigator for our active grants.At Enzyme by Design Inc. we use a combination of x-ray crystallography, biochemistry, enzyme kinetics, and molecular biology to engineer enzymes for use as cancer therapeutics. Our goal is to design safer drugs to reduce toxic side effects in cancer patients to not only save lives, but improve the quality of life of every patient who will be taking that drug.Additionally, I am deeply committed to mentoring the upcoming generation of scientists, particularly young women, and I am actively involved in contributing to the growth of Chicago's biotech ecosystem, aiming to establish it as a prominent hub in the field.𝐌𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞:▪ Molecular biology and Microbiology techniques▪ Structure-based design of mutants and site-directed mutagenesis▪ Continuous spectrophotometric enzyme-coupled kinetic assays▪ Biochemical and biophysical characterization▪ Protein X-Ray Crystallography▪ Intraperitoneal injections and tail vein nick blood draws in miceCheck the publications to which I have contributed as you scroll down below👇